Perspective Therapeutics, Inc. (CATX) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| VMT01 3.0 Millicuries Treated Patients (Total) | 10.00 | FY2026-Q1 |
| VMT-alpha-NET Safety Population (Patients Treated) | 56.00 | FY2025-Q4 |
Back to CATX overview · CATX earnings · CATX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.